Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Asset Writedowns and Impairment: 2016-2025

Historic Asset Writedowns and Impairment for SRx Health Solutions (SRXH) over the last 5 years, with Q2 2025 value amounting to $2.7 million.

  • SRx Health Solutions' Asset Writedowns and Impairment fell 6835.44% to $2.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.8 million, marking a year-over-year decrease of 6672.6%. This contributed to the annual value of $8.5 million for FY2023, which is 37164.18% up from last year.
  • Per SRx Health Solutions' latest filing, its Asset Writedowns and Impairment stood at $2.7 million for Q2 2025, which was down 6835.44% from $43000.0 recorded in Q1 2025.
  • SRx Health Solutions' Asset Writedowns and Impairment's 5-year high stood at $8.5 million during Q2 2024, with a 5-year trough of -$682000.0 in Q1 2023.
  • Over the past 4 years, SRx Health Solutions' median Asset Writedowns and Impairment value was $43000.0 (recorded in 2025), while the average stood at $1.2 million.
  • Per our database at Business Quant, SRx Health Solutions' Asset Writedowns and Impairment plummeted by 40720.72% in 2023 and then surged by 622000.0% in 2024.
  • SRx Health Solutions' Asset Writedowns and Impairment (Quarter) stood at $23000.0 in 2022, then soared by 486.96% to $135000.0 in 2023, then plummeted by 88.15% to $16000.0 in 2024, then soared by 16775.0% to $2.7 million in 2025.
  • Its Asset Writedowns and Impairment was $2.7 million in Q2 2025, compared to $43000.0 in Q1 2025 and $16000.0 in Q3 2024.